FIELD: medicine.
SUBSTANCE: group of inventions can be used for application of the testosterone analogue and the 5-HT1A agonist for manufacture of a pharmaceutical composition for sexual dysfunction treatment. A pharmaceutical composition for sexual dysfunction treatment including a testosterone analogue (dihydrotestosterone) and a 5-HT1A agonist is also claimed. At that, the 5-HT1A agonist is released essentially in one hour and the testosterone analogue - 3.5-5.5 hours before sexual activity.
EFFECT: treatment of male and female sexual dysfunction.
10 cl
Authors
Dates
2018-03-05—Published
2012-06-20—Filed